Novo Nordisk says it is gradually phasing out human insulin pens globally
Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...
health-e8h
MSF condemns Novo Nordisk double standard in diabetes care
The decision by Novo Nordisk to discontinue the insulin pens will force patients to revert to syringes, complicating diabetes care for millions of people.
Why maker of ‘magic’ weight-loss drug semaglutide wants copies banned
US Food and Drug Administration (FDA) regulations allow human drug compounding — in which licensed pharmacists or physicians ...
Gen X Is Getting Plastic Surgery Right
They came of age without fillers or selfies, now they’re approaching aesthetic interventions in their own unique way.
Ariana Grande’s evolution from ‘tonnes of filler’ to ‘gaunt’ trolling as experts reveal why her face has changed so much
ARIANA Grande shot to fame aged 16 as an innocent-looking Nickelodeon star with bright red hair. But since then, the child actress-turned-pop star has undergone a full transformation – one ...
The Link9d
Skinny at all costs
A Common Sense Media study conducted on body image and the media found that, between 1999 and 2006, hospitalization for ...
Novo's new obesity drug, Wegovy in race to becoming top selling franchise
Novo Gains Fueled by Ozempic and Wegovy Fade | The drugmaker's shares have ... of CagriSema that would allow its two drug ...
The Daily Telegraph9d
My experience of a weight-loss drug was hell – I felt like I was being poisoned
Mounjaro is similar to Ozempic or Wegovy, but as well as working on GLP-1 receptors ... Learn from my mistakes: don’t put ...
Novo’s New Obesity Drug Is Targeting the Most Dramatic Weight Loss Yet
The drugmaker hopes to show CagriSema leads to at least 25% weight loss, without increased side effects. Its lead in a ...